These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. Rhee H; Thomas P; Shepherd B; Gustafson S; Vela I; Russell PJ; Nelson C; Chung E; Wood G; Malone G; Wood S; Heathcote P J Urol; 2016 Oct; 196(4):1261-7. PubMed ID: 27220897 [TBL] [Abstract][Full Text] [Related]
13. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Meissner VH; Rauscher I; Schwamborn K; Neumann J; Miller G; Weber W; Gschwend JE; Eiber M; Heck MM Eur Urol; 2022 Aug; 82(2):156-160. PubMed ID: 34887117 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Margel D; Bernstine H; Groshar D; Ber Y; Nezrit O; Segal N; Yakimov M; Baniel J; Domachevsky L Radiology; 2021 Nov; 301(2):379-386. PubMed ID: 34463555 [TBL] [Abstract][Full Text] [Related]
15. Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging. Meijer D; van Leeuwen PJ; Donswijk ML; Boellaard TN; Schoots IG; van der Poel HG; Hendrikse HN; Oprea-Lager DE; Vis AN BJU Int; 2022 Jan; 129(1):54-62. PubMed ID: 34028165 [TBL] [Abstract][Full Text] [Related]
16. The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer. Duan H; Iagaru A Cancer Imaging; 2022 Sep; 22(1):45. PubMed ID: 36057766 [TBL] [Abstract][Full Text] [Related]
17. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT). Heetman JG; Lavalaye J; Polm PD; Soeterik TFW; Wever L; Paulino Pereira LJ; van der Hoeven EJRJ; van Melick HHE; van den Bergh RCN Eur Urol Oncol; 2024 Apr; 7(2):204-210. PubMed ID: 37296065 [TBL] [Abstract][Full Text] [Related]